Michael Thomas Selected Research

Michael Thomas Research Topics

Disease

115	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 06/2002
91	Neoplasms (Cancer) 03/2022 - 04/2002
37	Lung Neoplasms (Lung Cancer) 10/2022 - 04/2004
22	Disease Progression 12/2021 - 03/2012
15	Neoplasm Metastasis (Metastasis) 01/2022 - 09/2003
14	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2022 - 01/2011
10	Brain Neoplasms (Brain Tumor) 01/2022 - 08/2015
9	Neutropenia 06/2022 - 05/2007
9	Infections 10/2021 - 05/2007
9	Fatigue 04/2021 - 03/2012
8	Adenocarcinoma of Lung 02/2022 - 11/2008
7	Diarrhea 02/2018 - 11/2002
6	Breast Neoplasms (Breast Cancer) 12/2021 - 12/2011
6	Pneumonia (Pneumonitis) 10/2021 - 11/2002
6	Exanthema (Rash) 02/2018 - 11/2002
5	Anemia 06/2022 - 08/2013
5	Adenocarcinoma 05/2021 - 04/2012
5	Carcinogenesis 01/2021 - 11/2002
5	Malignant Mesothelioma 01/2021 - 01/2009
5	Fibrosis (Cirrhosis) 01/2019 - 01/2011
5	Carcinoma (Carcinomatosis) 01/2019 - 04/2002
4	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2021 - 07/2014
4	Hypertension (High Blood Pressure) 01/2020 - 03/2011
4	Febrile Neutropenia 01/2020 - 05/2007
4	Pain (Aches) 11/2019 - 12/2016
4	Asthma (Bronchial Asthma) 01/2016 - 01/2007
4	Sarcoma (Soft Tissue Sarcoma) 03/2014 - 03/2012
3	Wounds and Injuries (Trauma) 04/2021 - 10/2017
3	Body Weight (Weight, Body) 01/2021 - 02/2010
3	Visceral Leishmaniasis (Kala Azar) 01/2021 - 01/2018
3	Atherosclerosis 01/2021 - 01/2007
3	Ovarian Neoplasms (Ovarian Cancer) 01/2020 - 07/2013
3	Nausea 05/2017 - 11/2006
3	Shoulder Pain 12/2016 - 12/2014
3	Hemorrhage 05/2007 - 05/2004
2	Thrombocytopenia (Thrombopenia) 06/2022 - 05/2007
2	Clinical Deterioration 01/2021 - 01/2021
2	Inflammation (Inflammations) 11/2020 - 08/2008
2	Weight Gain 11/2020 - 10/2015

Drug/Important Bio-Agent (IBA)

22	Biomarkers (Surrogate Marker)IBA 03/2022 - 06/2002
19	Tyrosine Kinase InhibitorsIBA 01/2022 - 10/2010
17	ErbB Receptors (EGF Receptor)IBA 01/2021 - 03/2005
14	Proteins (Proteins, Gene)FDA Link 12/2021 - 07/2012
14	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 05/2007
13	PlatinumIBA 01/2022 - 12/2005
11	Anaplastic Lymphoma KinaseIBA 05/2022 - 03/2014
11	Pemetrexed (MTA)FDA Link 01/2021 - 05/2007
10	Immune Checkpoint InhibitorsIBA 03/2022 - 01/2019
9	Pharmaceutical PreparationsIBA 12/2019 - 08/2013
9	Erlotinib Hydrochloride (CP 358,774)FDA Link 06/2019 - 03/2011
8	Bevacizumab (Avastin)FDA Link 01/2020 - 02/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2017 - 01/2007
7	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2002
7	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018 - 03/2005
6	EnzymesIBA 11/2019 - 11/2002
5	Phosphotransferases (Kinase)IBA 02/2022 - 03/2005
5	CrizotinibIBA 01/2021 - 06/2013
5	DNA (Deoxyribonucleic Acid)IBA 08/2020 - 11/2008
5	AntigensIBA 05/2019 - 12/2011
5	Gefitinib (Iressa)FDA Link 02/2018 - 12/2005
4	osimertinibIBA 02/2022 - 01/2021
4	RNA (Ribonucleic Acid)IBA 08/2020 - 09/2007
4	Gemcitabine FDA Link 04/2020 - 07/2015
4	Etoposide (VP 16)FDA LinkGeneric 03/2020 - 04/2002
4	RamucirumabIBA 01/2020 - 08/2014
4	Docetaxel (Taxotere)FDA Link 01/2020 - 08/2014
4	GlycodelinIBA 01/2019 - 08/2015
3	Transaminases (Aminotransferases)IBA 06/2022 - 06/2013
3	BilirubinIBA 05/2022 - 01/2007
3	AlbuminsIBA 01/2022 - 03/2014
3	Glycoproteins (Glycoprotein)IBA 01/2022 - 08/2015
3	Peptides (Polypeptides)IBA 12/2021 - 07/2013
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2014
3	durvalumabIBA 01/2021 - 01/2020
3	130-nm albumin-bound paclitaxelIBA 01/2021 - 01/2020
3	Messenger RNA (mRNA)IBA 01/2021 - 08/2015
3	Cell-Free Nucleic AcidsIBA 12/2020 - 01/2016
3	Paclitaxel (Taxol)FDA LinkGeneric 03/2020 - 04/2010
3	Thymidylate SynthaseIBA 09/2015 - 09/2012
3	Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA 03/2013 - 12/2011
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2009 - 09/2007
2	HaptoglobinsIBA 05/2022 - 01/2022
2	Circulating Tumor DNAIBA 05/2022 - 12/2021
2	LipidsIBA 01/2021 - 10/2015
2	pembrolizumabIBA 01/2021 - 05/2019
2	NivolumabIBA 01/2021 - 11/2019
2	iberdomideIBA 01/2021 - 10/2018
2	CytokinesIBA 01/2021 - 05/2019

Therapy/Procedure

80	Therapeutics 03/2022 - 11/2002
30	Drug Therapy (Chemotherapy) 05/2022 - 04/2002
20	Radiotherapy 01/2022 - 04/2002
10	Palliative Care (Palliative Therapy) 10/2022 - 01/2016
7	Immunotherapy 03/2022 - 05/2019
6	Adjuvant Chemotherapy 06/2022 - 08/2004
4	Chemoradiotherapy 01/2020 - 12/2004
4	Neoadjuvant Therapy 05/2019 - 04/2002
3	Cranial Irradiation 01/2017 - 08/2015
2	Ambulatory Care (Outpatient Care) 01/2021 - 04/2014
2	Operative Surgical Procedures 01/2021 - 01/2020
2	Arthroplasty 10/2020 - 06/2019